[1] Stylianou IM, Bauer RC, Reilly MP, et al. Genetic basis of atherosclerosis:Insights from mice and humans[J].Circ Res, 2012,110(2):337-355.
[2] Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis[J].J Am Coll Cardiol, 2007,49(21):2073-2080.
[3] Unverdorben M, von Holt K, Winkelmann BR. Smoking and atherosclerotic cardiovascular disease:PartⅡ:role of cigarette smoking in cardiovascular disease development[J].Biomark Med, 2009,3(5):617-653.
[4] Santanam N, Thornhill BA, Lau JK, et al. Nicotinic acetylcholine receptor signaling in atherogenesis[J].Atherosclerosis, 2012;225:264-273.
[5] Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors:implications in tobacco-related vascular diseases[J].Pharmacol Ther, 2009,121(2):205-223.
[6] Ulloa L. The vagus nerve and the nicotine anti-inflammatory pathway[J].Nat Rev, 2005,4:673-684.
[7] Cucina A, Fuso A, Coluccia P, et al. Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor[J].J Surg Res, 2008,150(2):227-235.
[8] Strohschneider T, Oberhoff M, Hanke H, et al. Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques[J].Clin Invest, 1994,72(11):908-912.
[9] Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis[J].Nat Med, 2001,7(7):833-839.
[10] Lau PP, Li L, Merched AJ, Zhang AL, et al. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice[J].Arterioscler Thromb Vasc Biol, 2006,26(1):143-149.
[11] Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial diseas[J].Nature, 2008,452(7187):638-642.
[12] Wang Z, Wu W, et al. NF-ΚB pathway mediates vascular smooth muscle response to nicotine[J].Int J Biochem Cell Biol, 2012,45 (2):375-383.
[13] Chan SM, Ermann J, Su L, et al. Protein microarrays for multiplex analysis of signal transduction pathways[J].Nat Med, 2004,10(12),1390-1396.
[14] Wu JC, Chruscinski A, De Jesus Perez VA, et al. Cholinergic modulation of angiogenesis:role of the 7 nicotinic acetylcholine receptor[J].J Cell Biochem, 2009, 108(2):433-446.
[15] Kanda Y, Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the egfrerk pathway in rat vascular smooth muscle cells[J].Life Sci, 2007, 80(15):1409-1414.
[16] Bucerius J, Manka C, Schmaljohann J, et al. Feasibility of [18F]-2-fluuoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo[J].JACC Cardiovasc Imaging, 2012,5(5):528-536.
[17] Cooke JP. Imaging vascular nicotine receptors:a new window onto vascular disease[J].JACC Cardiovasc Imaging, 2012,5(5):537-539.
[18] Zhang G, Marshall AL, Thomas AL, et al. In vivo knockdown of nicotinic acetylcholine receptor alpha1 diminishes aortic atherosclerosis[J].Atherosclerosis, 2011,215(1):34-42.
[19] Li S, Zhao T, Xin H, et al. Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine[J].J Pharmacol Sci, 2004,94(3):334-338.
[20] Cooke JP, Ghebremariam YT. Endothelial nicotinic acetylcholine receptors and angiogenesis[J].Trends Cardiovas Med, 2008, 18(7):247-253.